Literature DB >> 27618167

Challenges Enrolling Children Into Traumatic Brain Injury Trials: An Observational Study.

Rachel M Stanley1,2, Michael D Johnson3, Cheryl Vance4, Lalit Bajaj5, Lynn Babcock6, Shireen Atabaki7, Danny Thomas8, Harold K Simon9, Daniel M Cohen2, Daniel Rubacalva10, P David Adelson11, Blake Bulloch12, Alexander J Rogers1, Prashant Mahajan13, Jill Baren14, Lois Lee15, John Hoyle16,17,18, Kimberly Quayle19, T Charles Casper20, J Michael Dean20, Nathan Kuppermann4.   

Abstract

OBJECTIVES: In preparation for a clinical trial of therapeutic agents for children with moderate-to-severe blunt traumatic brain injuries (TBIs) in emergency departments (EDs), we conducted this feasibility study to (1) determine the number and clinical characteristics of eligible children, (2) determine the timing of patient and guardian arrival to the ED, and (3) describe the heterogeneity of TBIs on computed tomography (CT) scans.
METHODS: We conducted a prospective observational study at 16 EDs of children ≤ 18 years of age presenting with blunt head trauma and Glasgow Coma Scale scores of 3-12. We documented the number of potentially eligible patients, timing of patient and guardian arrival, patient demographics and clinical characteristics, severity of injuries, and cranial CT findings.
RESULTS: We enrolled 295 eligible children at the 16 sites over 6 consecutive months. Cardiac arrest and nonsurvivable injuries were the most common characteristics that would exclude patients from a future trial. Most children arrived within 2 hours of injury, but most guardians did not arrive until 2-3 hours after the injury. There was a substantial range in types of TBIs, with subdural hemorrhages being the most common.
CONCLUSION: Enrolling children with moderate-to-severe TBI into time-sensitive clinical trials will require large numbers of sites and meticulous preparation and coordination and will prove challenging to obtain informed consent given the timing of patient and guardian arrival. The Federal Exception from Informed Consent for Emergency Research will be an important consideration for enrolling these children.
© 2016 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2017        PMID: 27618167     DOI: 10.1111/acem.13085

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  7 in total

Review 1.  Overview of Cochrane Systematic Reviews of Rehabilitation Interventions for Persons with Traumatic Brain Injury: A Mapping Synthesis.

Authors:  Vanessa M Young; Juan R Hill; Michele Patrini; Stefano Negrini; Chiara Arienti
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

2.  Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): a pilot randomized trial.

Authors:  Daniel K Nishijima; John M VanBuren; Seth W Linakis; Hilary A Hewes; Sage R Myers; Matthew Bobinski; Nam K Tran; Simona Ghetti; P David Adelson; Ian Roberts; James F Holmes; Walton O Schalick; J Michael Dean; T Charles Casper; Nathan Kuppermann
Journal:  Acad Emerg Med       Date:  2022-03-10       Impact factor: 5.221

3.  Delayed evolving epidural hematoma in the setting of a depressed skull fracture: A case report and review of the literature.

Authors:  Arthur Berg; Brett Voigt; Sanjeev Kaul
Journal:  Trauma Case Rep       Date:  2019-06-27

4.  Neurologic Outcomes Following Care in the Pediatric Intensive Care Unit.

Authors:  Sherrill D Caprarola; Sapna R Kudchadkar; Melania M Bembea
Journal:  Curr Treat Options Pediatr       Date:  2017-07-26

5.  Enrollment with and without exception from informed consent in a pilot trial of tranexamic acid in children with hemorrhagic injuries.

Authors:  Seth W Linakis; Nathan Kuppermann; Rachel M Stanley; Hilary Hewes; Sage Myers; John M VanBuren; T Charles Casper; Matthew Bobinski; Simona Ghetti; Walton O Schalick; Daniel K Nishijima
Journal:  Acad Emerg Med       Date:  2021-08-06       Impact factor: 3.451

6.  Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): study protocol for a pilot randomized controlled trial.

Authors:  Daniel K Nishijima; John VanBuren; Hilary A Hewes; Sage R Myers; Rachel M Stanley; P David Adelson; Sarah E Barnhard; Matthew Bobinski; Simona Ghetti; James F Holmes; Ian Roberts; Walton O Schalick; Nam K Tran; Leah S Tzimenatos; J Michael Dean; Nathan Kuppermann
Journal:  Trials       Date:  2018-10-30       Impact factor: 2.279

7.  A comprehensive systematic review of stakeholder attitudes to alternatives to prospective informed consent in paediatric acute care research.

Authors:  Jeremy Furyk; Kris McBain-Rigg; Bronia Renison; Kerrianne Watt; Richard Franklin; Theophilus I Emeto; Robin A Ray; Franz E Babl; Stuart Dalziel
Journal:  BMC Med Ethics       Date:  2018-11-20       Impact factor: 2.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.